Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ADAG

ADAG News

Newswire

07:11

Adagene and Palvella Receive FDA Fast Track Designations, Boosting Shares

04:26

Adagene Receives FDA Fast Track Designation for Muzastotug in Combination with KEYTRUDA for MSS mCRC Treatment.

04:06

Adagene shares jump 10.18% premarket after FDA grants Fast Track to muzastotug-Keytruda combo for MSS colorectal cancer.

15:27

Adagene's Muzastotug Receives FDA Fast Track Designation for Colorectal Cancer Treatment

10:01

Adagene shares jump 10.18% intraday after FDA grants Fast Track for muzastotug combo in MSS colorectal cancer.

View More

About ADAG

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More